Literature DB >> 12472657

HLA polymorphism in a Majorcan population of Jewish descent: comparison with Majorca, Minorca, Ibiza (Balearic Islands) and other Jewish communities.

C Crespí1, J Milà, N Martínez-Pomar, A Etxagibel, I Muñoz-Saa, D Priego, A Luque, J Pons, A Picornell, M Ramon, J A Castro, N Matamoros.   

Abstract

'Chueta' was the name given to the Catholic descendants of Jewish victims of the last Spanish Inquisition process in Majorca Island in the western Mediterranean. We have studied the allele distribution of HLA-A, -B, -Cw, -DRB1 and -DQB1 loci of 103 random, healthy, unrelated individuals belonging to the ancient Majorcan Jewish community, known locally as Chuetas, and 589 individuals from the Balearic population selected because of their typical Balearic - Majorca, Minorca or Ibiza - lineages and according to their ancestor's place of birth. Our aim was to establish the genetic relationship between Majorcan Chuetas, and Balearic and other Jewish and Mediterranean populations. Our results have shown that, to a remarkable extent, they have retained their biological identity, with a unique pattern, in terms of gene and haplotype frequencies, separate from the other populations of Majorca. The Chuetas were found to be more related to Moroccan and Libyan Jews than other Majorcans. Characteristic Jewish haplotypes, A26-B38-DRB1*13, A24-B38-DRB1*11, A1-B52-DRB1*15/16, were found in our study. Some peculiarities were observed in the distribution of common haplotypes among the three main Balearic Islands. The Ibizan population was genetically different from the other Balearic populations, with a high frequency of some haplotypes, for example, A29-Cw*16-B44-DRB1*07-DQB1*03; A1-Cw*07-B8-DRB1*03-DQB1*02. We also found a new haplotype, A25-Cw*12-B39-DRB1*11-DQB1*03(3.5%), in Ibizans and a more limited variability in the HLA alleles that were expressed, perhaps because of genetic isolation. The genetic diversity of the populations from Majorca and Minorca were similar and more related to the mainland Spanish population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472657     DOI: 10.1034/j.1399-0039.2002.600402.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  The distribution of polymorphic Alu insertions within the MHC class I HLA-B7 and HLA-B57 haplotypes.

Authors:  David S Dunn; Brian D Tait; Jerzy K Kulski
Journal:  Immunogenetics       Date:  2004-12-08       Impact factor: 2.846

2.  Complement component C7 deficiency in two Spanish families.

Authors:  Sonia Barroso; Berta Sánchez; Antonia José Alvarez; Margarita López-Trascasa; Amparo Lanuza; Rafael Luque; Ingeborg Wichmann; Antonio Núñez-Roldán
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

3.  Complement component C7 deficiency in a Spanish family.

Authors:  M F Vázquez-Bermúdez; S Barroso; K Walter; A J Alvarez; A Alarcón; M López-Trascasa; I Wichmann; F Aguilar; A Núñez-Roldán; B Sánchez
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

4.  Human leukocyte antigen profiles of latin american populations: differential admixture and its potential impact on hematopoietic stem cell transplantation.

Authors:  Esteban Arrieta-Bolaños; J Alejandro Madrigal; Bronwen E Shaw
Journal:  Bone Marrow Res       Date:  2012-11-18

5.  Association between the HLA-DQB1 polymorphisms and the susceptibility of chronic hepatitis B: A comprehensive meta-analysis.

Authors:  Jinmei Huang; Liangshi Xiong; Jin Wang; Yongfang Liu; Qirong Zhu; Jun Lei; Zhonghui Zhou
Journal:  Biomed Rep       Date:  2016-03-17

6.  Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.

Authors:  Caitlin N Dodd; Maria de Ridder; Wan-Ting Huang; Daniel Weibel; Maria Giner-Soriano; Silvia Perez-Vilar; Javier Diez-Domingo; Lawrence W Svenson; Salahddin M Mahmud; Bruce Carleton; Monika Naus; Jeffrey C Kwong; Brian J Murray; Lisen Arnheim-Dahlstrom; Lars Pedersen; Rosa Morros; Francisco Javier Puertas; Steven Black; Miriam Sturkenboom
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.